Platinum Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-134,989
| Closed | -$1.55M | – | 148 |
|
|
2022
Q4 | $1.55M | Sell |
134,989
-86,710
| -39% | -$995K | 0.06% | 89 |
|
|
2022
Q3 | $2.79M | Hold |
221,699
| – | – | 0.12% | 62 |
|
|
2022
Q2 | $2.35M | Hold |
221,699
| – | – | 0.09% | 76 |
|
|
2022
Q1 | $3.61M | Hold |
221,699
| – | – | 0.11% | 65 |
|
|
2021
Q4 | $3.07M | Buy |
221,699
+92,011
| +71% | +$1.27M | 0.09% | 80 |
|
|
2021
Q3 | $1.86M | Sell |
129,688
-39,027
| -23% | -$561K | 0.05% | 103 |
|
|
2021
Q2 | $2.67M | Hold |
168,715
| – | – | 0.06% | 85 |
|
|
2021
Q1 | $1.72M | Sell |
168,715
-289,360
| -63% | -$2.94M | 0.04% | 96 |
|
|
2020
Q4 | $3.41M | Sell |
458,075
-4,327
| -0.9% | -$32.2K | 0.08% | 65 |
|
|
2020
Q3 | $1.59M | Hold |
462,402
| – | – | 0.04% | 88 |
|
|
2020
Q2 | $2.2M | Sell |
462,402
-308,984
| -40% | -$1.47M | 0.05% | 80 |
|
|
2020
Q1 | $1.54M | Buy |
+771,386
| New | +$1.54M | 0.04% | 80 |
|